Published in J Clin Oncol on March 01, 2007
Bleomycin-induced flagellate erythema: A case report and review of the literature. Oncol Lett (2014) 0.82
Bleomycin-induced Flagellate Erythema: A Rare and Unique Drug Rash. West Indian Med J (2014) 0.76
Lesser known evil of a commonly used devil-bleomycin induced flagellate dermatitis. Indian Dermatol Online J (2014) 0.75
Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor. Case Rep Oncol Med (2015) 0.75
Trastuzumab-Associated Flagellate Erythema: Report in a Woman with Metastatic Breast Cancer and Review of Antineoplastic Therapy-Induced Flagellate Dermatoses. Dermatol Ther (Heidelb) (2015) 0.75
Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol (2006) 3.39
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood (2004) 2.89
A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg (2011) 2.43
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood (2011) 2.25
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol (2010) 1.88
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood (2003) 1.79
Primary effusion lymphoma. Oncologist (2007) 1.75
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation. Blood (2003) 1.73
Orbital involvement in Bing-Neel syndrome. J Neuroophthalmol (2010) 1.63
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma. Biol Blood Marrow Transplant (2011) 1.62
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia. Clin Cancer Res (2011) 1.46
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.40
Primary CNS lymphoma. Nat Clin Pract Neurol (2007) 1.20
Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am (2003) 1.15
Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol (2005) 1.11
Neurological manifestations of Waldenström macroglobulinemia. Nat Clin Pract Neurol (2008) 1.01
Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. J Hematop (2009) 1.00
Baseline total lesion glycolysis measured with (18)F-FDG PET/CT as a predictor of progression-free survival in diffuse large B-cell lymphoma: a pilot study. Am J Nucl Med Mol Imaging (2013) 0.98
Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol (2005) 0.97
Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood (2012) 0.97
Novel diagnostic approaches in Bing-Neel syndrome. Clin Lymphoma Myeloma Leuk (2011) 0.96
Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis. Cancer (2010) 0.96
Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy. N Engl J Med (2008) 0.92
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res (2002) 0.90
Case records of the Massachusetts General Hospital. Case 38-2005. A 29-year-old pregnant woman with the nephrotic syndrome and hypertension. N Engl J Med (2005) 0.90
Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience. Biol Blood Marrow Transplant (2009) 0.90
Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease. Leuk Lymphoma (2013) 0.89
Hodgkin lymphoma. J Natl Compr Canc Netw (2011) 0.88
HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature. Case Rep Oncol Med (2013) 0.83
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphoma. Haematologica (2012) 0.83
Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation. Exp Hematol (2003) 0.82
Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw (2015) 0.82
Bing-Neel Syndrome revisited. Clin Lymphoma Myeloma (2009) 0.80
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2017) 0.79
Chemotherapy is an effective first line treatment for early stage gastric mucosa-associated lymphoid tissue lymphoma. Cancer Treat Rev (2006) 0.79
Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study. Leuk Lymphoma (2013) 0.78
Quantitative monitoring of BCR/ABL transcript during STI-571 therapy. Leuk Lymphoma (2002) 0.78
Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors. J Hematop (2009) 0.75
Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia. N Engl J Med (2008) 0.75